Press Release

CREATIVE DIAGNOSTICS ANNOUNCES NEW TEST REAGENTS FOR DAPSONE



Creative Diagnostics has announced the launch of a range of new reagents for the analysis of Dapsone in food.

FOR IMMEDIATE RELEASE

01/12/2023

Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, has announced the launch of a range of new reagents for the analysis of Dapsone in food, including Dapsone Antibodies & Antigens, Dapsone ELISA Kits, and Dapsone Screen Tests.

Antibiotics, also known as antimicrobials, are naturally occurring metabolites of fungi or bacteria. With advances in medicinal chemistry, most modern antibiotics are semi-synthetic modifications of various natural compounds. Antibiotics can kill bacteria or prevent them from reproducing. For this reason, antibiotics are used in human and veterinary medicine to treat and prevent bacterial infections.

Antibiotics that may result in residues in meat, milk and eggs must not be used in foods intended for human consumption. If antibiotics have to be used in the prevention and treatment of animal diseases, a prohibition period must be observed until residues are negligible or no longer detectable. Concerns about antibiotic residues in foods of animal origin are twofold: one is the potential threat of direct toxicity of antibiotics to humans; the other is whether low-level exposure to antibiotics could lead to alterations in the microflora that could cause disease and possibly the development of resistant strains which could lead to failure of clinical antibiotic therapy.

Dapsone is a synthetic derivative of diamino-sulfone with anti-inflammatory and antibacterial properties. As a structural analog of para-aminobenzoic acid (PABA), dapsone inhibits dihydropteroate synthase (DHPS), an important enzyme in folate synthesis, resulting in depletion of the folate pool and a reduction in the amount of thymidylate available for DNA synthesis. Although the exact mechanism by which dapsone exerts its anti-inflammatory activity is not fully understood, this drug interferes with myeloperoxidase activation and oxidative damage in neutrophils and inhibits integrin-mediated neutrophil adhesion and chemotaxis. The anti-inflammatory activity of dapsone may be one of the reasons for the effect of topical administration.

Creative Diagnostics is dedicated to developing high quality assays to support the development of antibiotic testing. With years of research and experience of its technical staff, Creative Diagnostics has successfully developed a range of reagents for the analysis of Dapsone in food, including Dapsone Antibodies & Antigens, Dapsone ELISA Kits, and Dapsone Screen Tests.

For example, the Mouse Anti Diaminodiphenylsulfone/Dapsone monoclonal antibody, clone DDS (Cat. No CABT-L7871) is suitable for use in ELISA and LFIA. In addition, the Dapsone ELISA kit (Cat. No DEIA-BY055) can be used for the quantitative determination of Dapsone residues in milk.

For more information about these Dapsone Test Reagents, please visit https://www.creative-diagnostics.com/food-analysis/dapsone.html.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples. Its product portfolio covers a wide range of analytes including mycotoxins, drug residues, pesticides, contaminants, food allergens, food pathogens and vitamins. The company also assists customers in the rapid development, manufacture and commercialization of small molecule antigens, antibodies and food safety lateral flow strips for any market segment.

Tags:
Dapsone  |  Creative Diagnostics  |  

---

Organisation Profile:
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Our goal is to be a trusted source for all your assay development and manufacturing needs.






Press release contact details for Creative Diagnostics

NameCreative Diagnostics
Tel
Fax
Email
Websitehttps://www.creative-diagnostics.com/
OrganisationCreative Diagnostics
Address
Town
County0
Postcode11967




Other press releases from Creative Diagnostics

Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development
Creative Diagnostics Introduces TCID50 Assay Service for Determining Viral Titers
Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research
Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection
Creative Diagnostics Introduces Virus Yield Reduction Assay Service
Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers
Creative Diagnostics Announces Calprotectin Reagents for Inflammatory Disease Research
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 for Vascular Diseases
Creative Diagnostics Introduces qPCR Assay for Rapid Virus Detection and Quantification
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics Announces New Reagents for Bioanalysis of Antibody Drug Conjugates
Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
Creative Diagnostics Introduces New ELISA Kits to Accelerate Autoimmunity Research
Creative Diagnostics Launches Antimicrobial Synergy Testing Services
Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications
Creative Diagnostics Launches Checkerboard Assay Services
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services
Creative Diagnostics Launches Carbamazepine Test Reagents
Creative Diagnostics Launches Macrophage Migration Inhibitory Factor Reagents for Research Applications
Creative Diagnostics Announces New Test Reagents for Dapsone
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing Read more: https://www.digitaljournal.com/pr/news/getnews/creative-diagnostics-announces-new-mbc-assay-for-antibacterial-testing#ixzz8KcL65cji
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics Launches New P53 and TP53 Antibodies for Cancer Research
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Citrinin Test Reagents for Food Safety
Creative Diagnostics Announces Novel Agar Gel Precipitin Tests for Viral Antigen Detection
Creative Diagnostics Introduces Cutting-Edge Anti-AAV Antibody ELISA Kits for Gene Therapy Research
Creative Diagnostics Announces the Launch of Its Highly Sensitive Kanamycin ELISA Kit for Precise Antibiotic Detection
Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development
Creative Diagnostics Announces Comprehensive Vomitoxin Test Reagents for Food Safety Applications

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.